Clinical Characteristics of Campylobacter Bacteremia in Pediatric Population

Campylobacter infection in children is a common bacterial illness that mostly causes gastroenteritis and typically presents with diarrhea that may or may not be bloody, emesis, or abdominal pain. However, pediatric cases of bacteremia are rarely reported. Our objective was to report our tertiary center experience with Campylobacter bacteremia in a pediatric population. This 16-year retrospective study was performed at a tertiary-affiliated pediatric medical center. Data were collected from all patients with Campylobacter bacteremia during the study period. We identified 37 pediatric patients with Campylobacter bacteremia. Most children (n = 30, 81%) had severe underlying medical conditions, including malignancy and primary immunodeficiency. Only 7 (18.9%) children were previously healthy. The median age was 6.8 years, and children with severe underlying medical conditions were older than previously healthy children (9 vs. 1.2 years, P = .02). Most children present with fever and/or gastrointestinal symptoms. Campylobacter jejuni was the most common species (n = 30, 81%), and most isolates tested for antibiotic susceptibility were susceptible to macrolides. While one child was hospitalized in the intensive care unit because of septic shock, the outcome for all children was favorable. Campylobacter bacteremia is an uncommon complication of Campylobacter infection in children and has been reported more frequently among immunocompromised patients. Most children present with fever or gastrointestinal symptoms. Even in this predominantly immunocompromised population, the outcome is generally favorable, with most cases resolving without complications. Macrolides remain the antibiotic of choice for Campylobacter infections, including bacteremia.

Authors

Institutions

Publication Details

Journal
Clinical Pediatrics
Published
2026-06-12
DOI
https://doi.org/10.1177/00099228261456632
Primary Topic
Salmonella and Campylobacter epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Characteristics of Campylobacter Bacteremia in Pediatric Population

Nimrod Sachs, Haim Ben‐Zvi, Lee Galmor, Efraim Bilavsky et al.
Clinical Pediatrics
Salmonella and Campylobacter epidemiology
article

Clinical Characteristics of Campylobacter Bacteremia in Pediatric Population

Nimrod Sachs, Haim Ben‐Zvi, Lee Galmor, Efraim Bilavsky, Aviv Sever, Salvador Fisher, David Levy
article en

Abstract

Campylobacter infection in children is a common bacterial illness that mostly causes gastroenteritis and typically presents with diarrhea that may or may not be bloody, emesis, or abdominal pain. However, pediatric cases of bacteremia are rarely reported. Our objective was to report our tertiary center experience with Campylobacter bacteremia in a pediatric population. This 16-year retrospective study was performed at a tertiary-affiliated pediatric medical center. Data were collected from all patients with Campylobacter bacteremia during the study period. We identified 37 pediatric patients with Campylobacter bacteremia. Most children (n = 30, 81%) had severe underlying medical conditions, including malignancy and primary immunodeficiency. Only 7 (18.9%) children were previously healthy. The median age was 6.8 years, and children with severe underlying medical conditions were older than previously healthy children (9 vs. 1.2 years, P = .02). Most children present with fever and/or gastrointestinal symptoms. Campylobacter jejuni was the most common species (n = 30, 81%), and most isolates tested for antibiotic susceptibility were susceptible to macrolides. While one child was hospitalized in the intensive care unit because of septic shock, the outcome for all children was favorable. Campylobacter bacteremia is an uncommon complication of Campylobacter infection in children and has been reported more frequently among immunocompromised patients. Most children present with fever or gastrointestinal symptoms. Even in this predominantly immunocompromised population, the outcome is generally favorable, with most cases resolving without complications. Macrolides remain the antibiotic of choice for Campylobacter infections, including bacteremia.

Clinical Pediatrics
Tel Aviv University (IL), Rabin Medical Center (IL), Schneider Children's Medical Center (IL)
Good health and well-being
Openalex Percentile: Top 8%
Salmonella and Campylobacter epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.